1995
DOI: 10.1159/000246560
|View full text |Cite
|
Sign up to set email alerts
|

‘Milia en Plaque’ in the Supraclavicular Area

Abstract: ‘Milia en plaque’ is an unusual skin disease. Up to date only 6 cases have been reported, and all of them were located in the retro-auricular area. We report herein the first case of milia en plaque developed in the supraclavicular area. The absence of a known aetiologic factor in contrast to the previously published cases suggests that the present case belongs to the group of primary milia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
31
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(32 citation statements)
references
References 1 publication
(1 reference statement)
1
31
0
Order By: Relevance
“…1, Lesions are usually several centimeters in diameter and located on the head and neck, especially periauricularly 1,27-33 ; they may also be periorbital, 34-37 on the nasal bridge, 38 or truncal. 39,40 Although MEP has been reported in different age groups, it seems to be more common in middle-aged adults with a female predominance. MEP is asymptomatic.…”
Section: Milia En Plaquementioning
confidence: 99%
“…1, Lesions are usually several centimeters in diameter and located on the head and neck, especially periauricularly 1,27-33 ; they may also be periorbital, 34-37 on the nasal bridge, 38 or truncal. 39,40 Although MEP has been reported in different age groups, it seems to be more common in middle-aged adults with a female predominance. MEP is asymptomatic.…”
Section: Milia En Plaquementioning
confidence: 99%
“…The first case of nonretroauricular MEP was reported by Combemale and colleagues in 1995. 14 The patient had MEP on his left supraclavicular area. The first case of MEP involving eyelids was reported by Wong and Goh in 1998.…”
Section: Discussionmentioning
confidence: 99%
“…10 Treatment for MEP is limited. 10,14 Topical tretinoin has been used over 3 months with good response 2,3,7 or no response, 6,12,18 whereas intolerance was the main reason for patients to discontinue treatment. Simple evacuation is usually inadequate, but in superficially located milia, incision and expression has resulted in improvement.…”
Section: Discussionmentioning
confidence: 99%